alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
317375022 

 Michael Lee

 Chief Compliance Officer

 Email: mlee@spectraxe.com

January 5, 2024

Submitted via CFTC Portal

Assistant Secretary of the Commission for FOI, Privacy and Sunshine Acts Compliance 

Commodity Futures Trading Commission 

Three Lafayette Centre 

1155 21st Street, N.W. 

Washington, D.C. 20581

Re: FOIA Confidential Treatment Request – SpectrAxe 

Dear Assistant Secretary,

SpectrAxe LLC (“SpectrAxe”) hereby requests that the U.S. Commodity Futures Trading Commission 

(the “Commission”) accord confidential treatment under the Freedom of Information Act (the “FOIA”) to 

the attached SpectrAxe Fee Schedule (the “Fee Schedule”) and SpectrAxe Price Maker Discount 

Program (the “Discount Program”), which were submitted to the Commission on this date pursuant to 

Commission Regulation 40.6. This request pertains to all material set forth in the Fee Schedule and 

Discount Program, and additional redacted versions of the Fee Schedule and Discount Program are

included with this submission. SpectrAxe requests that confidential treatment be afforded as long as 

the Commission retains the Fee Schedule and Discount Program. In accordance with the Commission’s 

FOIA regulations, the Fee Schedule and Discount Program each bear the designation “Confidential 

Treatment Requested by SpectrAxe LLC”.

This request for confidential treatment under the FOIA is made pursuant to Commission Regulation 

145.9(d), as the Fee Schedule and Discount Program contain information that would reveal the trade 

secrets or confidential commercial or financial information of SpectrAxe and its affiliates. As required 

by Commission Regulation 145.9(d), SpectrAxe has submitted, together with this request, a written 

justification in support of the confidentiality of the Fee Schedule.

This request shall not be construed as a waiver of any protection from disclosure or confidential 

treatment under Commission Regulations or any other protection from disclosure or confidential 

treatment accorded by law, and SpectrAxe will rely on and invoke any such confidentiality protection 

with respect to the Fee Schedule and Discount Program. SpectrAxe requests that the Commission 

advise the undersigned, its representative, in advance of any disclosure of the Fee Schedule or 

Discount Program pursuant to the FOIA so that this request for confidential treatment may be further 

substantiated. SpectrAxe further requests that if any of the Confidential Information is to be disclosed 

to Congress or any other federal or state governmental agency or department, a request for confidential 

treatment be made by the Commission on SpectrAxe’s behalf, or that we be permitted to make such a 

request directly.

If you have any questions, please do not hesitate to contact Cheryl L. Isaac, K&L Gates, LLP at +1-

202-778-9089 or cheryl.isaac@klgates.com, or the undersigned at +1-929-581-0340 or 

mlee@spectraxe.com.

Very truly yours,

Michael Lee

Chief Compliance Officer

SpectrAxe, LLC
317375022

SpectrAxe, LLC

Fee Schedule
317375022

[REDACTED]
317375022

SpectrAxe, LLC

Discount Program
317375022

[REDACTED]
NOTE: This order is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

BETTY S. BAKER,

Claimant-Appellant,

v.

ERIC K. SHINSEKI, SECRETARY OF VETERANS

AFFAIRS,

Respondent-Appellee.

______________________ 

2014-7011

______________________ 

Appeal from the United States Court of Appeals for 

Veterans Claims in No. 11-600, Judge Lawrence B. Hagel.

______________________ 

ON MOTION

______________________ 

O R D E R

 Betty S. Baker moves for 90-day extension of time to 

file her principal brief. 

Upon consideration thereof,

 IT IS ORDERED THAT: 

Case: 14-7011 Document: 10 Page: 1 Filed: 02/28/2014
2 BAKER v. SHINSEKI

The motion is granted to the extent that Baker’s 

principal brief is due on or before May 27, 2014. No 

further extensions should be anticipated.

 FOR THE COURT

 /s/ Daniel E. O’Toole 

Daniel E. O’Toole 

Clerk of Court

s27

Case: 14-7011 Document: 10 Page: 2 Filed: 02/28/2014
EXHIBIT 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Annual Report of International Card Establishment
Inc. (the "Company") on Form 10-KSB/A for the period ended December 31, 2007 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Candace Mills, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.



Date: May 7, 2008                               By: /s/ CANDACE MILLS
                                                    ____________________________
                                                        Candace Mills
                                                        Chief Financial Officer
EXHIBIT 32

# CERTIFICATION

The
undersigned certify pursuant to 18 U.S.C. § 1350, that:

|(1) | The accompanying Quarterly Report on Form 10-Q for the period ended March 31,
          2006 fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the accompanying report fairly presents, in all
          material respects, the financial condition and results of operations of the
          Company.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Date:  May 8, 2006 | /s/ Bernard P. Aldrich               
|------------------ | -------------------------------------
|                   | President and Chief
Executive Officer

|Date:  May 8, 2006 | /s/ Robert M. Wolf     
|------------------ | -----------------------
|                   | Chief Financial Officer

---
(82 South. 894)

#### Ex parte VAUGHN.

(3 Div. 392.)

(Supreme Court of Alabama.

June 12, 1919.)

Certiorari to Court of Appeals.

Hill, Hill, Whiting & Thomas and Rushton, Williams & Crenshaw, all of Montgomery, for appellant.

J. Q. Smith, Atty. Gen., and Horace Wilkinson, Asst. Atty. Gen., for appellee.

SOMERVILLE, J.

Petition of Frank S. Vaughn for certiorari to the Court of Appeals to review and revise the judgment of the said court affirming the case of Frank S. Vaughn v. State of Alabama, 81 South. 417. Writ denied.
Exhibit 32.1
 Certification of President and Chief Executive Officer of Approach Resources Inc.
(Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002)
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and(2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 APPROACH RESOURCES INC.Date: November 3, 2010
    /s/ J. Ross CraftJ. Ross CraftPresident and Chief Executive Officer

(Principal Executive Officer)
**Exhibit 23**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

 

The Board of Directors 

GE Life and Annuity Assurance Company: 

 

We consent to the incorporation by reference in the registrationstatements (No. 333-67902, 333-69620, and 333-69786) on Form S-1 of GE Life and Annuity Assurance Company of our reports dated February 12, 2005, with respect to the consolidated balance sheets of GE Life and Annuity Assurance Company and subsidiaryas of December 31, 2004 and 2003, and the related statements of income, stockholder’s interest, and cash flows for each of the years in the three-year period ended December 31, 2004, and the related financial statement schedule,management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2004, and the effectiveness of internal control over financial reporting as of December 31, 2004, which reports appear in the December31, 2004, annual report on Form 10-K of GE Life and Annuity Assurance Company. 

 

Our report dated February 12, 2005, with respect to the consolidated balance sheets of GE Life and Annuity Assurance Company and subsidiary as of December 31, 2004 and 2003, the related statements of income,stockholder’s interest, and cash flows for each of the years in the three-year period ended December 31, 2004 refers to a change in accounting for certain nontraditional long-duration contracts and for separate accounts in 2004 and goodwill andother intangible assets in 2002. 

 

/s/ KPMG LLP 

 

Richmond, Virginia 

March 1, 2005
Sean Downey

Clearing Chief Compliance Officer & Head of Policy

CME Clearing

20 S. Wacker Drive Chicago, IL 60606 T 312 930 8167 Sean.Downey@cmegroup.com cmegroup.com

1

November 17, 2022

VIA Electronic Portal

CFTC FOIA Compliance Office

CommodityFuturesTradingCommission

Three Lafayette Centre

1155 21st Street, N.W

Washington, D.C. 20581

Re: FOIAConfidentialTreatment Request – Modifications to CME Clearing’s Risk Management 

Framework

To Whom it May Concern:

On November 17, 2022, Chicago Mercantile Exchange Inc. (“CME” or “CME Clearing”) submitted

modifications to its Risk Management Framework to the Commodity Futures Trading Commission

(“CFTC” or “Commission”) via the CFTC Portal under 40.6(a). The submission consisted of the 

submission cover sheet and letter and the modified Risk Management Framework (the “Confidential 

Information”).

Pursuant to Sections 8 and 8(a) of the Commodity Exchange Act (“CEA”), as amended, and Commission

Regulation 145.9(d), CME Clearing requests confidential treatment for the Confidential Information on

the grounds that disclosure of its contents would reveal confidential commercial information of the CME

Clearing. Pursuant to Commission Regulation 145.9(d)(5), CME Clearing requests that confidential

treatment be maintained until further notice from CME Clearing. We also request that the Commission

notify the undersigned immediately after receiving any FOIA request or any other court order, subpoena

or summons for same. Finally, we request that we be notified in the event the Commission intends

to disclose the C o n f i d e n t i a l I n f o r m a t i o n to Congress or to any other governmental

agency or unit pursuant to Section 8 of the CEA. CME Clearing does not waive its notification rights

under Section 8(f) of the CEA with respect to any subpoena or summons for the Confidential Information.

If you have any questions, please contact the undersigned at 312-930-8167 or via email at

sean.downey@cmegroup.com.

Sincerely,

/s/Sean Downey

Clearing Chief Compliance Officer & Head of Policy

CME Clearing
# C_2019413EN.01004101.xml

| 9.12.2019 | EN | Official Journal of the European Union | C 413/41 |
| --- | --- | --- | --- |

9.12.2019

EN

Official Journal of the European Union

C 413/41

---

Judgment of the General Court of 24 September 2019 — HSBC Holdings and Others v Commission

(Case T-105/17) (1)

(Competition - Agreements, decisions and concerted practices - Euro Interest Rate Derivatives sector - Decision establishing an infringement of Article 101 TFEU and Article 53 of the EEA Agreement - Manipulation of the Euribor interbank reference rates - Exchange of confidential information - Restriction of competition by object - Single and continuous infringement - Fines - Basic amount - Value of sales - Article 23(2) of Regulation (EC) No 1/2003 - Obligation to state reasons)

(2019/C 413/48)

Language of the case: English

Parties

Applicants: HSBC Holdings plc (London, United Kingdom), HSBC Bank plc (London), HSBC France (Paris, France) (represented by: K. Bacon QC, D. Bailey, Barrister, M. Simpson, Solicitor, and Y. Anselin and C. Angeli, lawyers)

Defendant: European Commission (represented by: M. Farley, B. Mongin and F. van Schaik, acting as Agents, and B. Lask, Barrister)

Re:

Application pursuant to Article 263 TFEU seeking, first, annulment in part of Commission Decision C(2016) 8530 final of 7 December 2016 relating to a proceeding under Article 101 TFEU and Article 53 of the EEA Agreement (AT.39914 — Euro Interest Rate Derivatives) and, second, a variation of the amount of the fine imposed on the applicants.

Operative part of the judgment

The Court:

| 1. | Annuls Article 2(b) of Commission Decision C(2016) 8530 final of 7 December 2016 relating to a proceeding under Article 101 TFEU and Article 53 of the EEA Agreement (Case AT.39914 — Euro Interest Rate Derivatives (EIRD)); |
| --- | --- |

1.

Annuls Article 2(b) of Commission Decision C(2016) 8530 final of 7 December 2016 relating to a proceeding under Article 101 TFEU and Article 53 of the EEA Agreement (Case AT.39914 — Euro Interest Rate Derivatives (EIRD));

| 2. | Dismisses the action as to the remainder; |
| --- | --- |

2.

Dismisses the action as to the remainder;

| 3. | Orders HSBC Holdings plc, HSBC Bank plc and HSBC France to bear their own costs; |
| --- | --- |

3.

Orders HSBC Holdings plc, HSBC Bank plc and HSBC France to bear their own costs;

| 4. | Orders the European Commission to bear its own costs. |
| --- | --- |

4.

Orders the European Commission to bear its own costs.

---

(1)  OJ C 112, 10.4.2017.

---
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 10-60897

Summary Calendar

HUGO MAIRENA-MONCADA, also known as Hugo Moncada Mairena,

Petitioner

v.

ERIC H. HOLDER, JR., U.S. ATTORNEY GENERAL,

Respondent

Petition for Review of an Order of the

Board of Immigration Appeals

BIA No. A088 809 225

Before BARKSDALE, STEWART, and PRADO, Circuit Judges.

PER CURIAM:*

Hugo Mairena-Moncada petitions for review of the Board of Immigration

Appeals’ (BIA) dismissal of his appeal from the Immigration Judge’s order

denying withholding of removal. The BIA’s determination that an alien is not

eligible for withholding of removal is a finding of fact reviewed under the

substantial evidence standard. E.g., Efe v. Ashcroft, 293 F.3d 899, 903 (5th Cir.

2002). “We will affirm the B[IA]’s decision unless the evidence compels a

contrary conclusion.” Carbajal-Gonzalez v. INS, 78 F.3d 194, 197 (5th Cir. 1996).

United States Court of Appeals

Fifth Circuit

F I L E D

November 29, 2011

Lyle W. Cayce

Clerk

Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

Case: 10-60897 Document: 00511678196 Page: 1 Date Filed: 11/29/2011
No. 10-60897

Mairena contends the BIA erred in determining he did not demonstrate

past persecution. Substantial evidence supports that finding. Mairena’s account

of verbal threats over a four to five month period and one physical attack does

not constitute past persecution. See Eduard v. Ashcroft, 379 F.3d 182, 187-88

(5th Cir. 2004); Abdel-Masieh v. INS, 73 F.3d 579, 583-84 (5th Cir. 1996). 

Mairena also contends the BIA erred in determining he had not

established a well-founded fear of future persecution. Because Mairena’s abovedescribed past treatment does not amount to persecution, it does not support a

presumption of future persecution. See 8 C.F.R. § 208.16(b)(1)(i) (showing of

past persecution results in rebuttable presumption life will be threatened in

future). Additionally, Mairena’s generalized fear of violence cannot constitute

a well-founded fear of future persecution. See Eduard, 379 F.3d at 190. 

Further, the reasonableness of Mairena’s fear of future persecution is

diminished because a number of Mairena’s family members have continued to

reside in Nicaragua and have remained unharmed. Id. at 193. 

DENIED.

2

Case: 10-60897 Document: 00511678196 Page: 2 Date Filed: 11/29/2011
KOR Reporting Inc

2136 Lassiter Field Dr NE, Marietta GA 30066

N/A

N/A

X

Exhibits: B-1, D-2, F-2, J, K, M-1, M-2, Q-1, Q-2, Z-3, 49 Checklist, 43 45 50 Checklist, BB, CC
N/A

N/A

N/A

678.612.6133

korfinancial.com

tmanuel@korfinancial.com

jthursby@korfinancial.com
Swap Data Repository Functions

X

X

X

X

X

X

All

2021-04-22

Delaware

N/A

N/A

December 31
Tara Manuel (Chief Compliance Officer and Head of Regulatory Products)

2136 Lassiter Field Dr NE

Marietta GA 30066

678.612.6133 tmanuel@korfinancial.com

21

March 22

KOR Reporting Inc

Jonathan Thursby, Chief Executive Officer
EXHIBIT 21

LIST OF SUBSIDIARIES

PuraMed Bioscience Inc., a Minnesota Corporation

12

---
| Name                                                        |   | Jurisdiction      of Organization |
|-------------------------------------------------------------|--------|-----------------------------------|
| Penn      Virginia Resource Finance Corporation             |   | Delaware                          |
| Penn      Virginia Operating Co., LLC                       |   | Delaware                          |
| Fieldcrest      Resources LLC                               |   | Delaware                          |
| K      Rail LLC                                             |   | Delaware                          |
| Loadout      LLC                                            |   | Delaware                          |
| Toney      Fork LLC                                         |   | Delaware                          |
| Suncrest      Resources LLC                                 |   | Delaware                          |
| Coal      Handling Solutions LLC                            |   | Delaware                          |
| Kingsport      Handling LLC                                 |   | Delaware                          |
| Maysville      Handling LLC                                 |   | Delaware                          |
| Covington      Handling LLC                                 |   | Delaware                          |
| PVR      Midstream LLC                                      |   | Delaware                          |
| PVR      Gas Resources, LLC                                 |   | Delaware                          |
| Connect      Energy Services, LLC                           |   | Delaware                          |
| Connect      Gas Pipeline LLC                               |   | Delaware                          |
| PVR      North Texas Gas Gathering, LLC                     |   | Delaware                          |
| Dulcet      Acquisition LLC                                 |   | Delaware                          |
| Thunder      Creek Gas Services, L.L.C. (25% Joint Venture) |   | Wyoming                           |
| PVR      Cherokee Gas Processing LLC                        |   | Oklahoma                          |
| PVR      East Texas Gas Processing, LLC                     |   | Delaware                          |
| PVR      Finco LLC                                          |   | Delaware                          |
| PVR      Gas Processing LLC                                 |   | Oklahoma                          |
| PVR      Hamlin, LLC                                        |   | Delaware                          |
| PVR      Natural Gas Gathering LLC                          |   | Oklahoma                          |
| PVR      Oklahoma Natural Gas Gathering LLC                 |   | Oklahoma                          |

----
1110 Brickell Avenue

Suite 430k-200

Miami, FL 33131

https://derivs.ftx.us/

1

April 8, 2022

VIA COMMISSION PORTAL

Christopher J. Kirkpatrick

Secretary, Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581 

Re: Commission Regulation 40.6(a) – Rule Certification

LedgerX LLC Submission No. 22-04

Dear Mr. Kirkpatrick:

LedgerX LLC (d/b/a FTX US Derivatives) (the “Company”) hereby notifies the 

Commodity Futures Trading Commission (the “Commission”), pursuant to Section 5c(c) of 

the Commodity Exchange Act (the “CEA”) and Commission Regulation 40.6(a), that it is 

certifying the attached amendments to its Rulebook. The attached amendments will become 

effective on April 22, 2022. 

A concise explanation and analysis of the changes and amendments, and their 

compliance with applicable provisions of the CEA, including the Core Principles and the 

Commission’s Regulations, are as follows.

LedgerX has updated its Rulebook to remove nine (9) previously self-certified product 

rules in Section 12 of the Rulebook that do not have any current open interest (Rules 12.1 

through 12.5, Rules 12.9 through 12.11, and Rule 12.16) and renumber the remaining products 

accordingly. All these changes are consistent with DCM Core Principle 2 in that they

establish the terms and conditions under which contracts are to be traded. They are also 

consistent with DCO Core Principle C in that they limit the eligibility of specified products

for clearing based on trading volume. The changes to Rules 12.1, 12.2, 12.3, 12.4, and 12.5 

are also consistent with SEF Core Principle 2 in that they establish the terms and conditions 

under which contracts are to be traded.

The changes and amendments to the Rulebook are reflected in a redlined copy 

designated as Appendix A. The final version of the revised Rulebook is attached at 

Appendix B.

The Company certifies that the above changes and amendments comply with the CEA 

and Commission Regulations thereunder. The Company additionally certifies that it has 

concurrently posted a copy of this submission letter and the attachments hereto on the Company 

website at https://derivs.ftx.us. The Company is not aware of any or substantive opposing 

views to the changes and amendments.
1110 Brickell Avenue

Suite 430k-200

Miami, FL 33131

https://derivs.ftx.us/

2

Please contact the undersigned at brian@ftx.us if you have any questions or you would 

otherwise like to discuss this further.

Sincerely,

Brian G. Mulherin

General Counsel, FTX US Derivatives